Category: Dangerous Drugs

New Mexico Dangerous Drugs – FDA Conflicts of Interest Compromise Our Safety

  |     |  
Last Modified on Mar 16, 2024

Recent allegations of research collaboration between the FDA’s top drug official – Dr. Janet Woodcock – and a pharmaceutical company underscore the potential for conflicts of interests and the high stakes involved in drug marketing. In fact, over the years the FDA has been involved in many conflicts of interest involving dangerous drugs. In August… read more


New Reports Link Avandia To Increased Risk Of Heart Attack

  |     |  
Last Modified on Mar 16, 2024

This past week new studies reported that Avandia poses a substantially greater risk of heart attacks for its users. Avandia is a diabetes drug prescribed to thousands of diabetics in New Mexico and throughout the United States. In one study, published by the AMA, researchers studied more than 227,000 people who took Avandia and found… read more


DANGEROUS DRUG – Reglan

  |     |  
Last Modified on Mar 16, 2024

Reglan is a prescription drug pushed by pharmaceutical companies to patients to treat Gastroesophageal reflux (GER) Gastroesophageal reflux disease (GERD). Many studies dating back from the 1970s have shown that Reglan is ineffective in resolving GER and GERD. A 2006 study published in Nature Clinical Practice: Gastroenterology & Hepatology concluded that “the evidence base for… read more


Darvon/Darvocet Pulled From The Market

  |     |  
Last Modified on Mar 16, 2024

Last week, the FDA finally pulled propoxyphene – sold as Darvon and Darvocet – from the U.S. market. For nearly 50 years concerns have been raised over the side effects of Darvon/Darvocet usage, including its toxicity even at low levels and its highly addictive properties. Additionally, it has not been shown to be very effective… read more


Topamax Linked To Birth Defects

  |     |  
Last Modified on Mar 16, 2024

The New York Times reports that Topamax, manufactured by Johnson & Johnson, has been linked to birth defects, such as a higher risk of developing cleft lips and palates, genital malformations, and cranial malformations. Topamax is an anti-seizure and migraine drug used in the treatment of migraines and epilepsy. It is also used in the… read more


Doctors With Questionable Records Hired By Drug Companies

  |     |  
Last Modified on Mar 16, 2024

ProPublica, an independent news organization, has been investigating the connection between physicians and pharmaceutical companies, and how pharmaceutical company payments influence physician prescription practices, including the prescription of dangerous drugs such as Avandia, Levaquin, and Meridia. This in-depth report reveals that hundreds of doctors received payments from drug companies who had been accused of professional… read more


Topamax May Alter Effectiveness Of Birth Control Pills

  |     |  
Last Modified on Mar 16, 2024

Recent reports indicate that in addition to problems such as cleft palates and cleft lip from taking Topamax, Topamax may cause oral contraceptives to lose their effectiveness. Topamax (topiramate) is a popular migraine and seizure medication that has been recently revised by the FDA as a “Class D” pregnancy drug – i.e. one where significant… read more



Yaz Investigated For Increased Risk Of Blood Clots

  |     |  
Last Modified on Mar 16, 2024

Many types of birth control pills create risks of blood clots. However, new birth control research suggests that certain types of pills create an even higher risk of blood clots than others. Birth control pills that contain Drospirenone – such as Yaz, Yasmin, and Beyaz contain a two to three-time higher risk for developing blot… read more


Yaz Required To Provide New Information On Warning Labels

  |     |  
Last Modified on Mar 16, 2024

The Food and Drug Administration (FDA) has recently issued documents recommending that birth control pills such as Yaz should contain additional warnings concerning the risk of blood clots. The FDA noted that patients and doctors should be informed about the risks. A statement from FDA scientists provides, “We believe that, because of the consistency in… read more